Active transcytosis and new opportunities for cancer nanomedicine
Source abstract
Abstract
New evidence suggests that the mechanism of nanoparticle entry into solid tumours may be driven by an active process. This insight paves the way for approaches to enhance the efficiency of nanomedicine delivery by harnessing active transport mechanisms, and encourage researchers to rethink how tumours are treated.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Chan, W. C. W. Acc. Chem. Res. 50, 627–632 (2017).10.1021/acs.accounts.6b00629 ↗
2. Nakamura, H., Jun, F. & Maeda, H. Expert Opin. Drug Deliv. 12, 53–64 (2015).10.1517/17425247.2014.955011 ↗
3. Wilhelm, S. et al. Nat. Rev. Mater 1, 16014 (2016).10.1038/natrevmats.2016.14 ↗
4. Shi, J., Kantoff, P., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).10.1038/nrc.2016.108 ↗
5. Sindhwani, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-019-0566-2 (2020).10.1038/s41563-019-0566-2 ↗
6. Hobbs, S. K. et al. Proc. Natl Acad. Sci. USA 95, 4607–4612 (1998).10.1073/pnas.95.8.4607 ↗
7. Schnitzer, J. E. Am. J. Physiol. Heart Circ. Physiol. 262, H246–H254 (1992).10.1152/ajpheart.1992.262.1.H246 ↗
8. Dvorak, H. F., Nagy, J. A., Dvorak, J. T. & Dvorak, A. M. Am. J. Pathol. 133, 95–109 (1988).
9. Oh, P. et al. Nat. Med. 20, 1062–1068 (2014).
10. Liu, Y. et al. Nano Lett. 19, 8010–8020 (2019).10.1021/acs.nanolett.9b03211 ↗
11. Detampel, P. et al. PloS ONE 14, e0223339 (2019).10.1371/journal.pone.0223339 ↗
12. Ayloo, S. & Gu, C. Curr. Opinion Neurobiol. 57, 32–38 (2019).10.1016/j.conb.2018.12.014 ↗
13. Wiley, D. T., Webster, P., Gale, A. & Davis, M. E. Proc. Natl Acad. Sci. USA 110, 8662–8667 (2013).10.1073/pnas.1307152110 ↗
14. Zhou, Q. et al. Nat. Nanotechnol. 14, 799–809 (2019).10.1038/s41565-019-0485-z ↗
15. Ruan, G., Agrawal, A., Marcus, A. I. & Nie, S. J. Am. Chem. Soc. 129, 14759–14766 (2007).10.1021/ja074936k ↗
16. Ruoslahti, E. Adv. Drug Deliv. Rev. 110–111, 3–12 (2017).10.1016/j.addr.2016.03.008 ↗
17. Schmid, D. et al. Nat. Commun. 8, 1747 (2017).10.1038/s41467-017-01830-8 ↗
18. Ledford, H. Nature 497, 544–544 (2013).
19. Syn, N. L., Teng, M. W. L., Mok, T. S. K. & Soo, R. A. Lancet Oncol. 18, e731–e741 (2017).10.1016/S1470-2045(17)30607-1 ↗
20. Jiang, W. et al. Nat. Biomed. Eng. 1, 0029 (2017).10.1038/s41551-017-0029 ↗
21. Reinhard, K. et al. Science 367, 446–453 (2020).10.1126/science.aay5967 ↗
22. Sahin, U. et al. Nature 547, 222–226 (2017).10.1038/nature23003 ↗
23. Yuan, H. et al. Nat. Nanotechnol. 12, 763–769 (2017).10.1038/nnano.2017.69 ↗
24. Chen, Q. et al. Nat. Commun. 7, 13193 (2016).10.1038/ncomms13193 ↗
25. Kulkarni, A. et al. Proc. Natl Acad. Sci. USA 113, E2104–E2113 (2016).10.1073/pnas.1603455113 ↗